Skip to main content
. 2020 Mar 11;19(5):3578–3586. doi: 10.3892/ol.2020.11457

Figure 2.

Figure 2.

Kaplan-Meier survival curves for patients with non-small cell lung cancer. (A) Patients with low miR-665 levels had longer survival time than those with high miR-665 expression (log-rank P=0.009). (B) High miR-665 expression was associated with poor overall survival in patients with TNM stages I–II (log-rank P=0.031). (C) High miR-665 expression predicted poor overall survival in patients with advanced TNM stage (log-rank P=0.046). miR-665, miRNA-665.